166 related articles for article (PubMed ID: 14599813)
1. Engineered long terminal repeats of retroviral vectors enhance transgene expression in hepatocytes in vitro and in vivo.
Yamaguchi K; Itoh K; Ohnishi N; Itoh Y; Baum C; Tsuji T; Nagao T; Higashitsuji H; Okanoue T; Fujita J
Mol Ther; 2003 Nov; 8(5):796-803. PubMed ID: 14599813
[TBL] [Abstract][Full Text] [Related]
2. High expression of transgenes mediated by hybrid retroviral vectors in hepatocytes: comparison of promoters from murine retroviruses in vitro and in vivo.
Ohnishi N; Itoh K; Itoh Y; Baum C; Higashitsuji H; Yamaguchi K; Tsuji T; Okanoue T; Fujita J
Gene Ther; 2002 Feb; 9(4):303-6. PubMed ID: 11896470
[TBL] [Abstract][Full Text] [Related]
3. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
Couture LA; Mullen CA; Morgan RA
Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
[TBL] [Abstract][Full Text] [Related]
4. Efficient gene transfer by hybrid retroviral vectors to murine spermatogenic cells.
Danno S; Itoh K; Baum C; Ostertag W; Ohnishi N; Kido T; Tomiwa K; Matsuda T; Fujita J
Hum Gene Ther; 1999 Jul; 10(11):1819-31. PubMed ID: 10446922
[TBL] [Abstract][Full Text] [Related]
5. A retroviral vector suitable for ultrasound image-guided gene delivery to mouse brain.
Jang J; Yoon K; Hwang DW; Lee DS; Kim S
Gene Ther; 2012 Apr; 19(4):396-403. PubMed ID: 21900964
[TBL] [Abstract][Full Text] [Related]
6. The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF.
Baum C; Itoh K; Meyer J; Laker C; Ito Y; Ostertag W
J Virol; 1997 Sep; 71(9):6323-31. PubMed ID: 9261349
[TBL] [Abstract][Full Text] [Related]
7. Deletion of a negatively acting sequence in a chimeric GATA-1 enhancer-long terminal repeat greatly increases retrovirally mediated erythroid expression.
Testa A; Lotti F; Cairns L; Grande A; Ottolenghi S; Ferrari G; Ronchi A
J Biol Chem; 2004 Mar; 279(11):10523-31. PubMed ID: 14701820
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting the performance of different long terminal repeats in the retroviral vector.
Kim S; Lee K; Kim MD; Kang S; Joo CW; Kim JM; Kim SH; Yu SS; Kim S
Biochem Biophys Res Commun; 2006 May; 343(4):1017-22. PubMed ID: 16574062
[TBL] [Abstract][Full Text] [Related]
9. RNA polymerase III control elements are required for trans-activation by the murine retroviral long terminal repeat sequences.
Hwang YW; Yoo NK; Yang HM; Choi SY
Biochem Biophys Res Commun; 2015 Jan; 456(1):110-5. PubMed ID: 25446107
[TBL] [Abstract][Full Text] [Related]
10. Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential.
Weber EL; Cannon PM
Hum Gene Ther; 2007 Sep; 18(9):849-60. PubMed ID: 17767401
[TBL] [Abstract][Full Text] [Related]
11. Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1.
Mertz JA; Mustafa F; Meyers S; Dudley JP
J Virol; 2001 Mar; 75(5):2174-84. PubMed ID: 11160721
[TBL] [Abstract][Full Text] [Related]
12. Protection of hematopoietic cells from O(6)-alkylation damage by O(6)-methylguanine DNA methyltransferase gene transfer: studies with different O(6)-alkylating agents and retroviral backbones.
Jansen M; Bardenheuer W; Sorg UR; Seeber S; Flasshove M; Moritz T
Eur J Haematol; 2001 Jul; 67(1):2-13. PubMed ID: 11553261
[TBL] [Abstract][Full Text] [Related]
13. Retroviral vectors for high-level transgene expression in T lymphocytes.
Engels B; Cam H; Schüler T; Indraccolo S; Gladow M; Baum C; Blankenstein T; Uckert W
Hum Gene Ther; 2003 Aug; 14(12):1155-68. PubMed ID: 12908967
[TBL] [Abstract][Full Text] [Related]
14. Upstream conserved sequences of mouse leukemia viruses are important for high transgene expression in lymphoid and hematopoietic cells.
Wahlers A; Kustikova O; Zipfel PF; Itoh K; Koester M; Heberlein C; Li Z; Schiedlmeier B; Skerka C; Fehse B; Baum C
Mol Ther; 2002 Sep; 6(3):313-20. PubMed ID: 12231166
[TBL] [Abstract][Full Text] [Related]
15. Insertion of two independent enhancers in the long terminal repeat of a self-inactivating vector results in high-titer retroviral vectors with tissue-specific expression.
Fassati A; Bardoni A; Sironi M; Wells DJ; Bresolin N; Scarlato G; Hatanaka M; Yamaoka S; Dickson G
Hum Gene Ther; 1998 Nov; 9(17):2459-68. PubMed ID: 9853513
[TBL] [Abstract][Full Text] [Related]
16. In vivo analysis of retroviral enhancer mutations in hematopoietic cells: SP1/EGR1 and ETS/GATA motifs contribute to long terminal repeat specificity.
Wahlers A; Zipfel PF; Schwieger M; Ostertag W; Baum C
J Virol; 2002 Jan; 76(1):303-12. PubMed ID: 11739695
[TBL] [Abstract][Full Text] [Related]
17. Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.
Ketteler R; Glaser S; Sandra O; Martens UM; Klingmüller U
Gene Ther; 2002 Apr; 9(8):477-87. PubMed ID: 11948372
[TBL] [Abstract][Full Text] [Related]
18. High-resolution analysis of cytosine methylation in the 5ĺong terminal repeat of retroviral vectors.
Wang L; Robbins PB; Carbonaro DA; Kohn DB
Hum Gene Ther; 1998 Nov; 9(16):2321-30. PubMed ID: 9829531
[TBL] [Abstract][Full Text] [Related]
19. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.
Baum C; Hegewisch-Becker S; Eckert HG; Stocking C; Ostertag W
J Virol; 1995 Dec; 69(12):7541-7. PubMed ID: 7494260
[TBL] [Abstract][Full Text] [Related]
20. Efficient gene transfer and expression in primary B lymphocytes.
Overell RW; Weisser KE; Hess BW; Ziegler SF; Pleiman CM; Maliszewski C; Grabstein KH
J Immunol Methods; 1991 Jul; 141(1):53-62. PubMed ID: 1865123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
